Abstract:Aims We aimed to investigate the effect and mechanism of pleiotropic chemokine CCL24 in heart failure. Methods and results Compared with normal donators, the expression of CCL24 and number of cardiac M2 macrophages in heart were higher in heart failure patients, the same as plasma CCL24 . Treatment with CCL24 antibody hindered Ang II (1500 ng/kg/min)–induced cardiac adverse remodeling through preventing cardiac hypertrophy and fibrosis. RNA-seq showed that CCL24/CCR3 axis was involved in immune and inflammatory responses. Single-cell analysis of cytometry by time of flight (CyTOF) revealed that CCL24 antibody decreased the M2 macrophage and monocyte polarization during Ang II stimulation. Immunofluorescence co-localization analysis confirmed the expression of CCR3 in macrophage and fibroblasts. Then, in vitro experiments confirmed that CCL24 / CCR3 axis was also involved in cardiac primary fibroblast activation through its G protein–coupled receptor function. Conclusion CCL24/CCR3 axis plays a crucial part in cardiac remodeling by stimulating M2 macrophage polarization and cardiac fibroblast activation. Graphical abstract Cardiac M2 macrophages, CCL24 and circulation CCL24 increased in heart failure patients. Treatment with CCL24 Ab hindered Ang II induced cardiac structural dysfunction and electrical remodeling. In CCL24 Ab group RNA-seq found that it was related to immune responses and hypertrophic cardiomyopathy, CytoF revealed M2 macrophages and monocytes d e creased obviously. In vitro,CCL24 promoted activation and migration of cardiac fibroblast.

CCL24/CCR3 Axis Plays a Central Role in Angiotensin II–induced Heart Failure by Stimulating M2 Macrophage Polarization and Fibroblast Activation